Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

N,N-Dimethylformamide (68-12-2)

DOI: https://doi.org/10.22427/NTP-DATA-DTXSID6020515


Study Results


Genetic Toxicology

An overview of Genetic Toxicology Mammalian Cell Mutagenicity study conclusions related to N,N-Dimethylformamide (68-12-2).
Mammalian Cell Mutagenicity
View
  • Negative
View
  • Negative
View
  • Positive
An overview of Genetic Toxicology Mammalian Cell Cytogenetics study conclusions related to N,N-Dimethylformamide (68-12-2).
Mammalian Cell Cytogenetics
CA SCE
An overview of Genetic Toxicology Drosophila Germ Cell Mutagenicity study conclusions related to N,N-Dimethylformamide (68-12-2).
Drosophila Germ Cell Mutagenicity
SLRL
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to N,N-Dimethylformamide (68-12-2).
Bacterial Mutagenicity
View
  • Negative

Citation Information


NTP. N,N-Dimethylformamide (68-12-2). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).

Publications


TOX-22 Toxicity Studies of N,N-Dimethylformamide (CASRN 68-12-2) Administered by Inhalation to F344/N Rats and B6C3F1Mice
Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals Environ. Mutagen. Vol. 8 (Suppl 7) (1986) 1-119
Myhr, B.C., and Caspary, W.J. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc. Environ. Molec. Mutagen. Vol. 12 (Suppl 13) (1988) 103-194
Mitchell, A.D., Rudd, C.J., and Caspary, W.J. Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for 63 coded chemicals tested at SRI International. Environ. Molec. Mutagen. Vol. 12 (Suppl 13) (1988) 37-102
McGregor, D.B., Brown, A., Cattanach, P., Edwards, I., McBride, D., and Caspary, W.J. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay to coded chemicals. II. 18 coded chemicals. Environ. Molec. Mutagen. Vol. 11 (1988) 91-118

Study Data


Toxicity and Carcinogenicity Studies


3-Month Evaluation of the Toxicity (C60913B) of Dimethylformamide (68-12-2) in F344 Rats via Whole Body Respiratory Exposure. NTP Special Study
3-Month Evaluation of the Toxicity (C60913B) of Dimethylformamide (68-12-2) in F344 Rats via Whole Body Respiratory Exposure. NTP Special Study
3-Month Evaluation of the Toxicity (C60913B) of Dimethylformamide (68-12-2) in F344 Rats via Whole Body Respiratory Exposure. NTP Special Study
3-Month Evaluation of the Toxicity (C60913B) of Dimethylformamide (68-12-2) in B6C3F1 Mice via Whole Body Respiratory Exposure. NTP Special Study
3-Month Evaluation of the Toxicity (C60913B) of Dimethylformamide (68-12-2) in F344/N Rats via Whole Body Respiratory Exposure
3-Month Evaluation of the Toxicity (C60913B) of Dimethylformamide (68-12-2) in B6C3F1 Mice via Whole Body Respiratory Exposure